Phosphoinositide 3-kinase: Diverse roles in immune cell activation

Annual Review of Immunology

Volumn 22, Issue , 2004, Pages 563-598

  Deane, Jonathan A ^a   Fruman, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

1 phosphatidylinositol 3 kinase; Lymphocyte activation; PI3K; Second messengers; Signal transduction

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; B LYMPHOCYTE RECEPTOR; CHEMOATTRACTANT; FC RECEPTOR; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G; LYMPHOCYTE ANTIGEN RECEPTOR; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; RECEPTOR; T LYMPHOCYTE RECEPTOR; WORTMANNIN;

ALLERGIC REACTION; CELL ACTIVATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME REGULATION; ENZYME SYNTHESIS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INFLAMMATION; LYMPHOCYTE MIGRATION; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RECEPTOR AFFINITY; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ENZYME ACTIVATION; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION;

EID: 1342292522     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.22.012703.104721     Document Type: Review

References (175)

1. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, et al. 2001. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70:535-602
2. Fruman DA, Cantley LC. 2002. Phosphoinositide 3-kinase in immunological systems. Semin. Immunol. 14:7-18
3. Koyasu S. 2003. The role of PI3K in immune cells. Nat. Immunol. 4:313-19
4. Okkenhaug K, Vanhaesebroeck B. 2003. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3:317-30
5. Fruman DA, Meyers RE, Cantley LC. 1998. Phosphoinositide kinases. Annu. Rev. Biochem. 67:481-507
6. Ohashi PS. 2002. T-cell signalling and autoimmunity: molecular mechanisms of disease. Nat. Rev. Immunol. 2:427-38
7. Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2:489-501
8. Fukao T, Koyasu S. 2003. PI3K and negative regulation of TLR signaling. Trends Immunol. 24:358-63
9. Rameh LE, Cantley LC. 1999. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274:8347-50
10. Stephens L, Ellson C, Hawkins P. 2002. Roles of PI3Ks in leukocyte chemotaxis and phagocytosis. Curr. Opin. Cell Biol. 14:203-13
11. Jimenez C, Hernandez C, Pimentel B, Carrera AC. 2002. The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras. J. Biol. Chem. 277:41556-62
12. Welch HC, Coadwell WJ, Stephens LR, Hawkins PT. 2003. Phosphoinositide 3-kinase-dependent activation of Rac. FEBS Lett. 546:93-97
13. Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, et al. 2000. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science 287:1049-53
14. Li Z, Jiang H, Xie W, Zhang Z, Smrcka AV, Wu D. 2000. Roles of PLC-β2 and -β33 and P13Kγ in chemoattractant-mediated signal transduction. Science 287:1046-49
15. Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, et al. 2000. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science 287:1040-46
16. Fruman DA, Rameh LE, Cantley LC. 1999. Phosphoinositide binding domains: embracing 3-phosphate. Cell 97:817-20
17. Lemmon MA, Ferguson KM. 2000. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem. J. 350(Part 1):1-18
18. Sato TK, Overduin M, Emr SD. 2001. Location, location, location: membrane targeting directed by PX domains. Science 294:1881-85
19. Kurosaki T. 2000. Functional dissection of BCR signaling pathways. Curr. Opin. Immunol. 12:276-81
20. Fruman DA, Satterthwaite AB, Witte ON. 2000. Xid-like phenotypes: a B cell signalosome takes shape. Immunity 13:1-3
21. Schaeffer EM, Schwartzberg PL. 2000. Tec family kinases in lymphocyte signaling and function. Curr. Opin. Immunol. 12:282-88
22. Cantrell D. 2002. Protein kinase B (Akt) regulation and function in T lymphocytes. Semin. Immunol. 14:19-26
23. Cantley LC, Neel BG. 1999. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA 96:4240-45
24. Kishimoto H, Hamada K, Saunders M, Backman S, Sasaki T, et al. 2003. Physiological functions of pten in mouse tissues. Cell Struct. Funct. 28:11-21
25. Rohrschneider LR, Fuller JF, Wolf I, Liu Y, Lucas DM. 2000. Structure, function, and biology of SHIP proteins. Genes Dev. 14:505-20
26. Kane LP, Lin J, Weiss A. 2000. Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12:242-49
27. Turner H, Kinet JP. 1999. Signalling through the high-affinity IgE receptor Fc εRI. Nature 402:B24-30
28. Ravetch JV, Holland S. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19:275-90
29. Beitz LO, Fruman DA, Kurosaki T, Cantley LC, Scharenberg AM. 1999. SYK is upstream of phosphoinositide 3-kinase in B cell receptor signaling. J. Biol. Chem. 274:32662-66
30. Fujimoto M, Poe JC, Inaoki M, Tedder TF. 1998. CD19 regulates B lymphocyte responses to transmembrane signals. Semin. Immunol. 10:267-77
31. Otero DC, Omori SA, Rickert RC. 2001. CD19-dependent activation of Akt kinase in B-lymphocytes. J. Biol. Chem. 276:1474-78
32. Wang Y, Brooks SR, Li X, Anzelon AN, Rickert RC, Carter RH. 2002. The physiologic role of CD 19 cytoplasmic tyrosines. Immunity 17:501-14
33. Anzelon AN, Wu H, Rickert RC. 2003. Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat. Immunol. 4:287-94
34. Perez OD, Nolan GP. 2002. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry. Nat. Biotechnol. 20:155-62
35. Perez OD, Kinoshita S, Hitoshi Y, Payan DG, Kitamura T, et al. 2002. Activation of the PKB/AKT pathway by ICAM-2. Immunity 16:51-65
36. Okada T, Maeda A, Iwamatsu A, Gotoh K, Kurosaki T. 2000. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity 13:817-27
37. Yamazaki T, Takeda K, Gotoh K, Takeshima H, Akira S, Kurosaki T. 2002. Essential immunoregulatory role for BCAP in B cell development and function. J. Exp. Med. 195:535-45
38. Liu Y, Rohrschneider LR. 2002. The gift of Gab. FEBS Lett. 515:1-7
39. Ingham RJ, Santos L, Dang-Lawson M, Holgado-Madruga M, Dudek P, et al. 2001. The Gabi docking protein links the B cell antigen receptor to the phosphatidylinositol 3-kinase/Akt signaling pathway and to the SHP2 tyrosine phosphatase. J. Biol. Chem. 276:12257-65
40. Itoh S, Itoh M, Nishida K, Yamasaki S, Yoshida Y, et al. 2002. Adapter molecule Grb2-associated binder 1 is specifically expressed in marginal zone B cells and negatively regulates thymus-independent antigen-2 responses. J. Immunol. 168:5110-16
41. Lynch DK, Daly RJ. 2002. PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2. EMBO J. 21:72-82
42. Inabe K, Ishiai M, Scharenberg AM, Freshney N, Downward J, Kurosaki T. 2002. Vav3 modulates B cell receptor responses by regulating phosphoinositide 3-kinase activation. J. Exp. Med. 195:189-200
43. Doody GM, Bell SE, Vigorito E, Clayton E, McAdam S, et al. 2001. Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation. Nat. Immunol. 2:542-47
44. Tedford K, Nitschke L, Girkontaite I, Charlesworth A, Chan G, et al. 2001. Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling. Nat. Immunol. 2:548-55
45. Han J, Luby-Phelps K, Das B, Shu X, Xia Y, et al. 1998. Role of substrates and products of PI3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 279:558-60
46. Fruman DA, Snapper SB, Yballe CM, Davidson L, Yu JY, et al. 1999. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283:393-97
47. Suzuki H, Terauchi Y, Fujiwara M, Aizawa S, Yazaki Y, et al. 1999. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 283:390-92
48. Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, et al. 2002. Impaired B and T cell antigen receptor signaling in p110δ PI 3-kinase mutant mice. Science 297:1031-34
49. Clayton E, Bardi G, Bell SE, Chantry D, Downes CP, et al. 2002. A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 196:753-63
50. Jou ST, Carpino N, Takahashi Y, Piekorz R, Chao JR, et al. 2002. Essential, nonredundant role for the phosphoinositide 3-kinase p110δ in signaling by the B-cell receptor complex. Mol. Cell. Biol. 22:8580-91
51. Deleted in proof
52. Suzuki H, Matsuda S, Terauchi Y, Fujiwara M, Ohteki T, et al. 2003. PI3K and Btk differentially regulate B cell antigen receptor-mediated signal transduction. Nat. Immunol. 4:280-86
53. 2+ mobilization. J. Exp. Med. 186:1897-910
54. Croker BA, Tarlinton DM, Cluse LA, Tuxen AJ, Light A, et al. 2002. The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J. Immunol. 168:3376-86
55. Khan WN, Alt FW, Gerstein RM, Malynn BA, Larsson I, et al. 1995. Defective B cell development and function in Btk-dencient mice. Immunity 3:283-99
56. Saito K, Tolias KF, Saci A, Koon HB, Humphries LA, et al. 2003. BTK regulates PtdIns-4,5-P2 synthesis. Importance for calcium signaling and PI3K activity. Immunity 19:669-77
57. Forssell J, Nilsson A, Sideras P. 1999. Bruton's tyrosine-kinase- deficient murine B lymphocytes fail to enter S phase when stimulated with anti-immunoglobulin plus interleukin-4. Scand. J. Immunol. 49:155-61
58. Leitges M, Schmedt C, Guinamard R, Davoust J, Schaal S, et al. 1996. Immunodeficiency in protein kinase cβ-deficient mice. Science 273:788-91
59. Bajpai UD, Zhang K, Teutsch M, Sen R, Wortis HH. 2000. Bruton's tyrosine kinase links the B cell receptor to nuclear factor κB activation. J. Exp. Med. 191:1735-44
60. Petro JB, Rahman SM, Ballard DW, Khan WN. 2000. Bruton's tyrosine kinase is required for activation of IκB kinase and nuclear factor κB in response to B cell receptor engagement. J. Exp. Med. 191:1745-54
61. Saijo K, Mecklenbrauker I, Santana A, Leitger M, Schmedt C, Tarakhovsky A. 2002. Protein kinase C β controls nuclear factor κB activation in B cells through selective regulation of the IκB kinase α. J. Exp. Med. 195:1647-52
62. Su TT, Guo B, Kawakami Y, Sommer K, Chae K, et al. 2002. PKC-B controls IκB kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 3:780-86
63. Yamazaki T, Kurosaki T. 2003. Contribution of BCAP to maintenance of mature B cells through c-Rel. Nat. Immunol. 4:780-786
64. Kaisho T, Takeda K, Tsujimura T, Kawai T, Nomura F, et al. 2001. IκB kinase α is essential for mature B cell development and function. J. Exp. Med. 193:417-26
65. Solvason N, Wu WW, Kabra N, Lund-Johansen F, Roncarolo MG, et al. 1998. Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells. J. Exp. Med. 187:1081-91
66. Brorson K, Brunswick M, Ezhevsky S, Wei DG, Berg R, et al. 1997. xid affects events leading to B cell cycle entry. J. Immunol. 159:135-43
67. Glassford J, Holman M, Banerji L, Clayton E, Klaus GG, et al. 2001. Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen receptor. J. Biol. Chem. 276:41040-48
68. Glassford J, Soeiro I, Skarell SM, Banerji L, Holman M, et al. 2003. BCR targets cyclin D2 via Btk and the p85α subunit of PI3-K to induce cell cycle progression in primary mouse B cells. Oncogene 22:2248-59
69. Fruman DA, Ferl GZ, An SS, Donahue AC, Satterthwaite AB, Witte ON. 2002. Phosphoinositide 3-kinase and Bruton's tyrosine kinase regulate overlapping sets of genes in B lymphocytes. Proc. Natl. Acad. Sci. USA 99:359-64
70. Yusuf I, Fruman DA. 2003. Regulation of quiescence in lymphocytes. Trends Immunol. 24:380-86
71. Martin P, Duran A, Minguet S, Gaspar ML, Diaz-Meco MT, et al. 2002. Role of ζ PKC in B-cell signaling and function. EMBO J. 21:4049-57
72. Kane LP, Weiss A. 2003. The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3. Immunol Rev. 192:7-20
73. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC. 2002. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell 10:151-62
74. Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, et al. 1998. Phosphorylation and activation of p70s6k by PDK1. Science 279:707-10
75. Grumont RJ, Strasser A, Gerondakis S. 2002. B cell growth is controlled by phosphatidylinosotol 3-kinase-dependent induction of Rel/NF-κB regulated c-myc transcription. Mol. Cell 10:1283-94
76. Donahue AC, Fruman DA. 2003. Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation. J. Immunol. 170:5851-60
77. Jacob A, Cooney D, Pradhan M, Coggeshall KM. 2002. Convergence of signaling pathways on the activation of ERK in B cells. J. Biol. Chem. 277:23420-26
78. Suzuki A, Kaisho T, Ohishi M, Tsukio-Yamaguchi M, Tsubata T, et al. 2003. Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J. Exp. Med. 197:657-67
79. Liu Q, Oliveira-Dos-Santos AJ, Mariathasan S, Bouchard D, Jones J, et al. 1998. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J. Exp. Med. 188:1333-42
80. Brauweiler A, Tamir I, Dal Porto J, Benschop RJ, Helgason CD, et al. 2000. Differential regulation of B cell development, activation, and death by the src homology 2 domain-containing 5′ inositol phosphatase (SHIP). J. Exp. Med. 191:1545-54
81. Costello PS, Gallagher M, Cantrell DA. 2002. Sustained and dynamic inositol lipid metabolism inside and outside the immunological synapse. Nat. Immunol. 3:1082-89
82. Harriague J, Bismuth G. 2002. Imaging antigen-induced PI3K activation in T cells. Nat. Immunol. 3:1090-96
83. Huppa JB, Gleimer M, Sumen C, Davis MM. 2003. Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat. Immunol. 4:749-55
84. Astoul E, Edmunds C, Cantrell DA, Ward SG. 2001. PI3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models. Trends Immunol. 22:490-96
85. Reynolds LF, Smyth LA, Norton T, Freshney N, Downward J, et al. 2002. Vav1 transduces T cell receptor signals to the activation of phospholipase C-γ1 via phosphoinositide 3-kinase-dependent and -independent pathways. J. Exp. Med. 195:1103-14
86. Parry RV, Rumbley CA, Vandenberghe LH, June CH, Riley JL. 2003. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-x(L), and IL-2 expression in primary human CD4 T lymphocytes. J. Immunol. 171:166-74
87. Rodriguez-Borlado L, Barber DF, Hernandez C, Rodriguez-Marcos MA, Sanchez A, et al. 2003. Phosphatidylinositol 3-kinase regulates the CD4/CD8 T cell differentiation ratio. J. Immunol. 170:4475-82
88. Melendez AJ, Gillooly DJ, Harnett MM, Allen JM. 1998. Aggregation of the human high affinity immunoglobulin G receptor (FcγRI) activates both tyrosine kinase and G protein-coupled phosphoinositide 3-kinase isoforms. Proc. Natl. Acad. Sci. USA 95:2169-74
89. Hobson JP, Rosenfeldt HM, Barak LS, Olivera A, Poulton S, et al. 2001. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 291:1800-3
90. Laffargue M, Calvez R, Finan P, Trifilieff A, Barbier M, et al. 2002. Phosphoinositide 3-kinase γ is an essential amplifier of mast cell function. Immunity 16:441-51
91. Truitt KE, Shi J, Gibson S, Segal LG, Mills GB, Imboden JB. 1995. CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase. J. Immunol. 155:4702-10
92. + T cells. J. Immunol. 158:4688-95
93. Eder AM, Dominguez L, Franke TF, Ashwell JD. 1998. Phosphoinositide 3-kinase regulation of T cell receptor-mediated interleukin-2 gene expression in normal T cells. J. Biol. Chem. 273:28025-31
94. + T cells: compulsory cytoskeletal alterations for the triggering of an intracellular calcium response. Eur. J. Immunol. 28:716-29
95. 2+ entry mechanism. J. Biol. Chem. 275:16242-50
96. Schaeffer EM, Debnath J, Yap G, McVicar D, Liao XC, et al. 1999. Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 284:638-41
97. Bunnell SC, Diehn M, Yaffe MB, Findell PR, Cantley LC, Berg LJ. 2000. Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. J. Biol. Chem. 275:2219-30
98. Liao XC, Littman DR. 1995. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 3:757-69
99. Liu KQ, Bunnell SC, Gurniak CB, Berg LJ. 1998. T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J. Exp. Med. 187:1721-27
100. + T cells. Immunity 11:399-409
101. Okkenhaug K, Wu L, Garza KM, La Rose J, Khoo W, et al. 2001. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2:325-32
102. Burr JS, Savage ND, Messah GE, Kimzey SL, Shaw AS, et al. 2001. Cutting edge: Distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL. J. Immunol. 166:5331-35
103. Harada Y, Tokushima M, Matsumoto Y, Ogawa S, Otsuka M, et al. 2001. Critical requirement for the membrane-proximal cytosolic tyrosine residue for CD28-mediated costimulation in vivo. J. Immunol. 166:3797-803
104. Kane LP, Mollenauer MN, Xu Z, Turck CW, Weiss A. 2002. Akt-dependent phosphorylation specifically regulates Cot induction of NFκB-dependent transcription. Mol. Cell. Biol. 22:5962-74
105. Kane LP, Andres PG, Rowland KC, Abbas AK, Weiss A. 2001. Akt provides the CD28 costimulatory signal for upregulation of IL-2 and IFN-γ but not TH2 cytokines. Nat. Immunol. 2:37-44
106. Jones RG, Elford AR, Parsons MJ, Wu L, Krawczyk CM, et al. 2002. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J. Exp. Med. 196:335-48
107. Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, et al. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16:769-77
108. Ohteki T, Parsons M, Zakarian A, Jones RG, Nguyen LT, et al. 2000. Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. J. Exp. Med. 192:99-104
109. Stahl M, Dijkers PF, Kops GJ, Lens SM, Coffer PJ, et al. 2002. The forkhead transcription factor FoxO regulates transcription of p27Kip1and Bim in response to IL-2. J. Immunol. 168:5024-31
110. Liu YC, Gu H. 2002. Cbl and Cbl-b in T-cell regulation. Trends Immunol. 23:140-43
111. Fang D, Wang HY, Fang N, Altman Y, Elly C, Liu YC. 2001. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3- kinase for ubiquitination in T cells. J. Biol. Chem. 276:4872-78
112. Thien CB, Bowtell DD, Langdon WY. 1999. Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT SLP-76 in c-Cbl-deficient thymocytes. J. Immunol 162:7133-39
113. Bachmaier K, Krawczyk C, Kozieradzki I, Kong YY, Sasaki T, et al. 2000. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403:211-16
114. Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, et al. 2000. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403:216-20
115. Fang D, Liu YC. 2001. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat. Immunol. 2:870-75
116. Yasuda T, Tezuka T, Maeda A, Inazu T, Yamanashi Y, et al. 2002. Cbl-b positively regulates Btk-mediated activation of phospholipase C-γ2 in B cells. J. Exp. Med. 196:51-63
117. Arron JR, Vologodskaia M, Wong BR, Naramura M, Kim N, et al. 2001. A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation. J. Biol. Chem. 276:30011-17
118. Rivera J. 2002. Molecular adapters in FcεRI signaling and the allergic response. Curr. Opin. Immunol. 14:688-93
119. Wilson BS, Pfeiffer JR, Surviladze Z, Gaudet EA, Oliver JM. 2001. High resolution mapping of mast cell membranes reveals primary and secondary domains of FcεRI LAT. J. Cell Biol. 154:645-58
120. Gu H, Saito K, Klaman LD, Shen J, Fleming T, et al. 2001. Essential role for Gab2 in the allergic response. Nature 412:186-90
121. Manetz TS, Gonzalez-Espinosa C, Arudchandran R, Xirasagar S, Tybulewicz V, Rivera J. 2001. Vav1 regulates phospholipase cγ activation and calcium responses in mast cells. Mol. Cell. Biol. 21:3763-74
122. Yang FC, Kapur R, King AJ, Tao W, Kim C, et al. 2000. Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells. Immunity 12:557-68
123. Ott VL, Cambier JC. 2000. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention? J. Allergy Clin. Immunol. 106:429-40
124. Parravicini V, Gadina M, Kovarova M, Odom S, Gonzalez-Espinosa C, et al. 2002. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 3:741-48
125. Lu-Kuo JM, Fruman DA, Joyal DM, Cantley LC, Katz HR. 2000. Impaired kit- but not FcεRI-initiated mast cell activation in the absence of phosphoinositide 3-kinase p85α gene products. J. Biol. Chem. 275:6022-29
126. Fukao T, Yamada T, Tanabe M, Terauchi Y, Ota T, et al. 2002. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat. Immunol. 3:295-304
127. 2+ influx by enhancing inositol 1,4,5-trisphosphate production. J. Biol. Chem. 276:17213-20
128. Windmiller DA, Backer JM. 2003. Distinct phosphoinositide 3-kinases mediate mast cell degranulation in response to G-protein-coupled versus Fcε RI receptors. J. Biol. Chem. 278:11874-78
129. Hata D, Kawakami Y, Inagaki N, Lantz CS, Kitamura T, et al. 1998. Involvement of Bruton's tyrosine kinase in FcεRI-dependent mast cell degranulation and cytokine production. J. Exp. Med. 187:1235-47
130. Rameh LE, Rhee SG, Spokes K, Kazlauskas A, Cantley LC, Cantley LG. 1998. Phosphoinositide 3-kinase regulates phospholipase Cγ-mediated calcium signaling. J. Biol. Chem. 273:23750-57
131. Araki N, Johnson MT, Swanson JA. 1996. A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J. Cell Biol. 135:1249-60
132. Swanson JA, Johnson MT, Beningo K, Post P, Mooseker M, Araki N. 1999. A contractile activity that closes phagosomes in macrophages. J. Cell. Sci. 112(Part 3):307-16
133. Cox D, Tseng CC, Bjekic G, Greenberg S. 1999. A requirement for phosphatidylinositol 3-kinase in pseudopod extension. J. Biol. Chem. 274:1240-47
134. Vieira OV, Botelho RJ, Rameh L, Brachmann SM, Matsuo T, et al. 2001. Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation. J. Cell Biol. 155:19-25
135. Marshall IG, Booth JW, Stambolic V, Mak T, Balla T, et al. 2001. Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fcγ receptor-mediated phagocytosis. J. Cell Biol. 153:1369-80
136. Deleted in proof
137. Gu H, Botelho RJ, Yu M, Grinstein S, Neel BG. 2003. Critical role for scaffolding adapter Gab2 in FcγR-mediated phagocytosis. J. Cell Biol. 161:1151-61
138. Gibbins JM, Briddon S, Shutes A, van Vugt MJ, van de Winkel JG, et al. 1998. The p85 subunit of phosphatidylinositol 3-kinase associates with the Fc receptor γ-chain and linker for activitor of T cells (LAT) in platelets stimulated by collagen and convulxin. J. Biol. Chem. 273:34437-43
139. Tridandapani S, Lyden TW, Smith JL, Carter JE, Coggeshall KM, Anderson CL. 2000. The adapter protein LAT enhances fcγ receptor-mediated signal transduction in myeloid cells. J. Biol. Chem. 275:20480-87
140. Patel JC, Hall A, Caron E. 2002. Vav regulates activation of Rac but not Cdc42 during FcγR-mediated phagocytosis. Mol. Biol. Cell 13:1215-26
141. Cox D, Dale BM, Kashiwada M, Helgason CD, Greenberg S. 2001. A regulatory role for Src homology 2 domain-containing inositol 5′-phosphatase (SHIP) in phagocytosis mediated by Fcγ receptors and complement receptor 3 (α(M)B(2); CD11b/CD18). J. Exp. Med. 193:61-71
142. Fratti RA, Backer JM, Gruenberg J, Corvera S, Deretic V. 2001. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J. Cell Biol. 154:631-44
143. Leverrier Y, Okkenhaug K, Sawyer C, Bilancio A, Vanhaesebroeck B, Ridley AJ. 2003. Class I PI3K p110β is required for apoptotic cell and Fcγ R-mediated phagocytosis by macrophages. J. Biol. Chem. 278:38437-42
144. Cox D, Greenberg S. 2001. Phagocytic signaling strategies: Fc(γ) receptor-mediated phagocytosis as a model system. Semin. Immunol. 13:339-45
145. Cox D, Berg JS, Cammer M, Chinegwundoh JO, Dale BM, et al. 2002. Myosin X is a downstream effector of PI(3)K during phagocytosis. Nat. Cell Biol. 4:469-77
146. Yokoyama WM, Plougastel BF. 2003. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3:304-16
147. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, et al. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223
148. Wang JW, Howson JM, Ghansah T, Desponts C, Ninos JM, et al. 2002. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science 295:2094-97
149. Long EO. 1999. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17:875-904
150. Trinchieri G. 2003. The choices of a natural killer. Nat. Immunol 4:509-10
151. Wu J, Cherwinski H, Spies T, Phillips JH, LanierLL. 2000. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells. J. Exp. Med. 192:1059-68
152. Wu J, Song Y, Bakker AB, Bauer S, Spies T, et al. 1999. An activating immunoreceptor complex formed by NKG2D DAP10. Science 285:730-32
153. Billadeau DD, Upshaw JL, Schoon RA, Dick CJ, Leibson PJ. 2003. NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat. Immunol. 4:557-64
154. Zompi S, Hamerman JA, Ogasawara K, Schweighoffer E, Tybulewicz VL, et al. 2003. NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases. Nat. Immunol. 4:565-72
155. Comer FI, Parent CA. 2002. PI 3-kinases PTEN: How opposites chemoattract. Cell 109:541-44
156. Iijima M, Huang YE, Devreotes P. 2002. Temporal and spatial regulation of chemotaxis. Dev. Cell 3:469-78
157. Servant G, Weiner OD, Herzmark P, Balla T, Sedat JW, Bourne HR. 2000. Polarization of chemoattractant receptor signaling during neutrophil chemotaxis. Science 287:1037-40
158. Weiner OD, Neilsen PO, Prestwich GD, Kirschner MW, Cantley LC, Bourne HR. 2002. A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat. Cell Biol. 4:509-13
159. Wang F, Herzmark P, Weiner OD, Srinivasan S, Servant G, Bourne HR. 2002. Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat. Cell Biol. 4:513-18
160. Welch HC, Coadwell WJ, Ellson CD, Ferguson GJ, Andrews SR, et al. 2002. P-Rex1, a PtdIns(3,4,5)P3- and GBγ-regulated guanine-nucleotide exchange factor for Rac. Cell 108:809-21
161. Weiner OD. 2002. Rac activation: P-Rex1 - a convergence point for PIP(3) and GBγ? Curr. Biol. 12:R429-31
162. Hannigan M, Zhan L, Li Z, Ai Y, Wu D, Huang CK. 2002. Neutrophils lacking phosphoinositide 3-kinase γ show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc. Natl. Acad. Sci. USA 99:3603-8
163. Vicente-Manzanares M, Rey M, Jones DR, Sancho D, Mellado M, et al. 1999. Involvement of phosphatidylinositol 3-kinase in stromal cell derived factor-1α-induced lymphocyte polarization and chemotaxis. J. Immunol. 163:4001-12
164. Sadhu C, Masinovsky B, Dick K, Sowell CG, Staunton DE. 2003. Essential role of phosphoinositide 3-kinase δ in neutrophil directional movement. J. Immunol. 170:2647-54
165. Vanhaesebroeck B, Jones GE, Allen WE, Zicha D, Hooshmand-Rad R, et al. 1999. Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nat. Cell Biol. 1:69-71
166. Dinauer MC. 2003. Regulation of neutrophil function by Rac GTPases. Curr. Opin. Hematol. 10:8-15
167. Cadwallader KA, Condliffe AM, McGregor A, Walker TR, White JF, et al. 2002. Regulation of phosphatidylinositol 3-kinase activity and phosphatidylinositol 3,4,5-trisphosphate accumulation by neutrophil priming agents. J. Immunol. 169:3336-44
168. Croker BA, Handman E, Hayball JD, Baldwin TM, Voigt V, et al. 2002. Rac2-deficient mice display perturbed T-cell distribution and chemotaxis, but only minor abnormalities in T(H)1 responses. Immunol. Cell Biol. 80:231-40
169. Fox JA, Ung K, Tanlimco SG, Jirik FR. 2002. Disruption of a single Pten allele augments the chemotactic response of B lymphocytes to stromal cell-derived factor-1. J. Immunol. 169:49-54
170. Cherukuri A, Dykstra M, Pierce SK. 2001. Floating the raft hypothesis: Lipid rafts play a role in immune cell activation. Immunity 14:657-60
171. Sedwick CE, Altman A. 2002. Ordered just so: lipid rafts and lymphocyte function. Sci. STKE 2002: www.stke.org/cgi/ content/full/OC_sigtrans;2002/122/ re2
172. Aman MJ, Tosello-Trampont AC, Ravichandran K. 2001. Fc γ RIIB1/SHIP-mediated inhibitory signaling in B cells involves lipid rafts. J. Biol. Chem. 276:46371-78
173. Wymann MP, Zvelebil M, Laffargue M. 2003. Phosphoinositide 3-kinase signaling - which way to target? Trends Pharmacol. Sci. 24:366-76
174. Walmsley MJ, Ooi SK, Reynolds LF, Smith SH, Ruf S, et al. 2003. Critical roles for Rac1 and Rac2 GTPases in B cell development and signaling. Science 302:459-62
175. Han A, Saijo K, Mecklenbrauker I, Tarakhovsky A, Nussenzweig MC. 2003. Bam32 links the B cell receptor to ERK and JNK and mediates B cell proliferation but not survival. Immunity 19:621-32